Related Experiment Video
Updated: May 10, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Bartlomiej Przychodzen1, Andres Jerez, Kathryn Guinta
1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Abstract:
Recently, recurrent mutations of spliceosomal genes were frequently identified in myeloid malignancies, as well as other types of cancers. One of these spliceosomal genes, U2AF1, was affected by canonical somatic mutations in aggressive type of myeloid malignancies. We hypothesized that U2AF1 mutations causes defects of splicing (missplicing) in specific genes and that such misspliced genes might be important in leukemogenesis. We analyzed RNA deep sequencing to compare splicing patterns of 201 837 exons between the cases with U2AF1 mutations (n = 6) and wild type (n = 14). We identified different alternative splicing patterns in 35 genes comparing cells with mutant and wild-type U2AF1. U2AF1 mutations are associated with abnormal splicing of genes involved in functionally important pathways, such as cell cycle progression and RNA processing. In addition, many of these genes are somatically mutated or deleted in various cancers. Of note is that the alternative splicing patterns associated with U2AF1 mutations were associated with specific sequence signals at the affected splice sites. These novel observations support the hypothesis that U2AF1 mutations play a significant role in myeloid leukemogenesis due to selective missplicing of tumor-associated genes.
Insights
Mutations in the U2AF1 spliceosomal gene cause abnormal RNA splicing in myeloid malignancies. This selective missplicing of genes involved in cell cycle and RNA processing contributes to leukemogenesis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Recurrent mutations in spliceosomal genes are common in myeloid malignancies and cancers.
- U2AF1 mutations are specifically found in aggressive myeloid malignancies.
Purpose of the Study:
- To investigate if U2AF1 mutations lead to splicing defects (missplicing) in specific genes.
- To determine if these misspliced genes are significant in the development of leukemia (leukemogenesis).
Main Methods:
- RNA deep sequencing was used to compare splicing patterns.
- Exon splicing patterns were analyzed between cases with U2AF1 mutations (n=6) and wild-type (n=14).
Main Results:
- Different alternative splicing patterns were identified in 35 genes when comparing mutant and wild-type U2AF1 cells.
- U2AF1 mutations are linked to abnormal splicing in genes critical for cell cycle progression and RNA processing.
- Alternative splicing patterns correlated with specific sequence signals at affected splice sites.
Conclusions:
- U2AF1 mutations are associated with selective missplicing of genes implicated in cancer.
- These findings support the role of U2AF1 mutations in myeloid leukemogenesis through the missplicing of tumor-associated genes.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cancers Originate from Somatic Mutations in a Single Cell
